Imaging Diagnostic Systems Inc.
5307 NW 35th Court
Plantation,
FL 33309
United States - Map
Phone: 954-581-9800
Fax: 954-581-0555
Web Site: http://www.imds.com
| Imaging Diagnostic Systems, Inc., a development stage medical technology company, engages in commercializing medical imaging equipment worldwide. The company offers computed tomography laser mammography (CTLM) for detecting breast cancer. CTLM is an imaging modality offering the potential of molecular functional imaging, which could visualize the process of angiogenesis and might be used to distinguish between benign and malignant tissue. It is designed to be used in conjunction with mammography. CTLM also reveals information about blood distribution in the breast. The company installed its CTLM system in Italy, Germany, Poland, the Czech Republic, the Peoples Republic of China, Malaysia, and the United Arab Emirates. It also offers Laser Imager for Lab Animals (LILA), an optical helical micro-CT scanner that is designed to image numerous compounds, primarily green fluorescent protein, derived from the DNA of jellyfish. The LILA scanner is targeted at pharmaceutical developers and researchers who monitor cancer growth and who use multimodality small animal imaging in their clinical research. The company was founded in 1993 and is headquartered in Plantation, Florida. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mrs. Linda B. Grable , 72
Chairman and Chief Exec. Officer |
$
143.00K |
$
0 | Mr. Allan L. Schwartz , 67
Co-Founder, Chief Financial Officer, Principal Accounting Officer, Exec. VP, Sec., Director and Member of Exec. Committee |
$
188.00K |
$
0 | Ms. Deborah O'Brien , 45
Sr. VP and Member of Exec. Committee |
$
137.00K |
$
0 | Prof. Dr. Eric Milne M.D.,
Chief Radiologist of Clinical Research |
N/A
| N/A | Dr. Rajesh Suresh Sheth ,
Managing Director of India Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.00 (3.45%) 
Profile
